Clinical trialNCT05143840RecruitingPhase 2Interventional

Asciminib as Initial Therapy for Patients With Chronic Myeloid Leukemia in Chronic Phase

SponsorUniversity of Alabama at BirminghamEnrollment100Adult CMLChronic Myeloid Leukemia, Chronic PhaseLeukemia, MyeloidLeukemia,Myeloid, Chronic

View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Jorge S Cortes, MD
University of Alabama at Birmingham
Principal Investigator
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

8 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

University of Alabama at Birmingham
Birmingham, Alabama, United States
Omer Jamy, MD
Recruiting
Winship Cancer Institute Emory University
Atlanta, Georgia, United States
Anthony M Hunter, MD
Recruiting
Georgia Cancer Center at Augusta University
Augusta, Georgia, United States
Vamsi Kota, MD
Recruiting
Karmanos Cancer Institute
Detroit, Michigan, United States
Recruiting
Roswell Park Comprehensive Cancer Center
Buffalo, New York, United States
Recruiting
Memorial Sloan Kettering Cancer Center
New York, New York, United States
Recruiting
Huntsman Cancer Institute
Salt Lake City, Utah, United States
Recruiting
Froedtert Hospital & the Medical College of Wisconsin
Milwaukee, Wisconsin, United States
Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 22 Apr 2022
Primary completion: 29 Feb 2032
Completion: 29 Feb 2032
Last update posted: 29 Jun 2026
Registered enrollment: 100
Registry id: NCT05143840

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.